Wilmington Healthcare wins first client for new NHS transformation tracker
July 24, 2018 |
Product helps pharma identify opportunities and tailor solutions to a changing NHS
Healthcare intelligence provider Wilmington Healthcare has won its first client for an innovative new service that helps pharma keep abreast of change within local NHS organisations and better understand their strategic priorities. The Healthcare Transformation Tracker, which is a Key Account Management (KAM) tool, enables pharma to search lengthy NHS documents at the touch of a button to identify opportunities within specific regions and allocate resources appropriately.
The product, which is now being used by a top pharma company, helps industry follow NHS change within three critical categories – disease and therapy areas; infrastructure, such as NHS estates, finance and transport, and the NHS transformation agenda.
Searches can be conducted across NHS organisations, such as trusts and Clinical Commissioning Groups (CCGs), within a Sustainability and Transformation Partnership footprint. Documents that can be perused include STP plans, operating plans, commissioning plans and board meeting papers.
For example, by searching on the term ‘diabetes’, a client can find out what individual STPs and their constituent organisations are saying about it; how services are being redesigned for it in different geographical regions and what is happening to enable this change with regards to NHS infrastructure.
To ensure they are targeting the appropriate personnel within local NHS organisations, pharma can also use the tracker to keep abreast of structural changes. For example, it can find out if a specific group of CCGs has formally merged or is acting as a single entity.
The service replaces Wilmington Healthcare’s STP tracker, that was launched in 2016, and reflects the radical change that continues in the NHS as ten areas prepare to become Integrated Care Systems (ICSs).
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Accessing key influencers within the NHS is becoming increasingly difficult for pharma. When companies do secure meetings, they should have a sound grasp of what is happening within a specific locality and go armed with a tailored solution that meets clearly identified needs.
“The transformation tracker helps pharma operate in this strategic and highly targeted way by enabling it to quickly extract relevant snippets of information from lengthy strategic documents and follow changes within the NHS as they unfold in different ways across different parts of the country.”
Ends
Notes to Editors
For more information, please contact:
Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool
Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23
The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for...
NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
With a stormy outlook predicted for health and care, Wilmington Healthcare’s Oli Hudson looks at the five critical shifts that pharma should focus on as it navigates its way through...
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria...
We must be candid about our use of healthcare data if we want to win back public trust
As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to...
Wilmington Healthcare appoints new Solutions Director
Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Understanding the role of provider collaboratives
Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Integrated NHS finances: what do they mean for High Cost Drugs?
Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas